← Back to Screener
Masimo Corporation (MASI)
Price$178.45
Favorite Metrics
Price vs S&P 500 (26W)14.59%
Price vs S&P 500 (4W)-9.41%
Market Capitalization$9.34B
All Metrics
P/CF (Annual)42.86x
Book Value / Share (Quarterly)$13.84
P/TBV (Annual)10.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-9.14%
Cash Flow / Share (Quarterly)$3.71
Price vs S&P 500 (YTD)33.02%
Gross Margin (TTM)61.90%
Net Profit Margin (TTM)-9.92%
EPS (TTM)$-2.77
10-Day Avg Trading Volume0.63M
EPS Excl Extra (TTM)$-2.77
Revenue Growth (5Y)5.95%
EPS (Annual)$-2.83
ROI (Annual)-12.16%
Gross Margin (Annual)61.90%
Net Profit Margin (5Y Avg)1.02%
Cash / Share (Quarterly)$2.92
Revenue Growth QoQ (YoY)-26.38%
ROA (Last FY)-8.92%
Revenue Growth TTM (YoY)-16.03%
EBITD / Share (TTM)$6.49
ROE (5Y Avg)-3.70%
Operating Margin (TTM)20.30%
Cash Flow / Share (Annual)$3.71
P/B Ratio12.94x
P/B Ratio (Quarterly)9.98x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)6.36x
Net Interest Coverage (TTM)8.29x
ROA (TTM)-7.38%
EV / EBITDA (TTM)27.83x
EPS Incl Extra (Annual)$-2.83
Current Ratio (Annual)2.49x
Quick Ratio (Quarterly)1.30x
3-Month Avg Trading Volume1.37M
52-Week Price Return17.61%
EV / Free Cash Flow (Annual)50.27x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$12.84
P/S Ratio (Annual)6.11x
Asset Turnover (Annual)0.90x
52-Week High$179.00
Operating Margin (5Y Avg)12.80%
EPS Excl Extra (Annual)$-2.83
CapEx CAGR (5Y)-20.95%
Tangible BV CAGR (5Y)-12.89%
26-Week Price Return23.33%
Quick Ratio (Annual)1.30x
13-Week Price Return28.89%
Total Debt / Equity (Annual)0.73x
Current Ratio (Quarterly)2.49x
Enterprise Value$9,707.241
Revenue / Share Growth (5Y)7.63%
Asset Turnover (TTM)0.74x
Book Value / Share Growth (5Y)-11.47%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.20x
Pretax Margin (Annual)17.85%
Cash / Share (Annual)$2.92
3-Month Return Std Dev70.10%
Gross Margin (5Y Avg)50.89%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)4.11%
EBITDA Interim CAGR (5Y)5.93%
ROE (Last FY)-21.01%
Net Interest Coverage (Annual)8.31x
EPS Basic Excl Extra (Annual)$-2.83
P/FCF (TTM)48.34x
Receivables Turnover (TTM)5.09x
EV / Free Cash Flow (TTM)50.27x
Total Debt / Equity (Quarterly)0.73x
EPS Incl Extra (TTM)$-2.77
Receivables Turnover (Annual)5.34x
ROI (TTM)-10.33%
P/S Ratio (TTM)6.11x
Pretax Margin (5Y Avg)11.21%
Revenue / Share (Annual)$28.49
Tangible BV / Share (Annual)$12.84
Forward P/E30.14x
Free OCF CAGR (5Y)8.07%
Price vs S&P 500 (52W)-17.49%
Year-to-Date Return37.16%
5-Day Price Return-0.04%
EPS Normalized (Annual)$-2.83
ROA (5Y Avg)-0.24%
Net Profit Margin (Annual)-9.92%
Month-to-Date Return0.29%
Cash Flow / Share (TTM)$3.51
EBITD / Share (Annual)$6.51
Operating Margin (Annual)20.30%
LT Debt / Equity (Annual)0.72x
P/CF (TTM)42.86x
ROI (5Y Avg)-0.86%
LT Debt / Equity (Quarterly)0.72x
EPS Basic Excl Extra (TTM)$-2.77
P/TBV (Quarterly)10.76x
P/B Ratio (Annual)9.98x
Inventory Turnover (TTM)1.70x
Pretax Margin (TTM)17.86%
Book Value / Share (Annual)$13.84
Price vs S&P 500 (13W)26.02%
Beta1.14x
P/FCF (Annual)48.34x
Revenue / Share (TTM)$29.31
ROE (TTM)-17.21%
52-Week Low$125.94
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.06
4.06
3.60
3.53
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
MASIMasimo Corporation | 6.11x | 5.95% | 61.90% | 20.30% | $178.45 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.00 |
TMDXTransMedics Group, Inc. Common Stock | 6.56x | 88.21% | 59.92% | 17.93% | $113.13 |
LIVNLivaNova PLC Ordinary Shares | 2.59x | 8.24% | 68.04% | 14.09% | $65.81 |
ITGRInteger Holdings Corporation | 1.66x | 11.55% | 27.39% | 11.90% | $89.32 |
AXGNAxogen, Inc. Common Stock | 8.90x | 14.93% | 74.31% | -3.49% | $37.23 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $39.68 |
BLFSBioLife Solutions Inc. | 10.84x | 14.87% | 64.56% | -17.26% | $22.19 |
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.57 |
CBLLCeriBell, Inc. Common Stock | 8.96x | — | 87.89% | -65.57% | $21.13 |
CVCapsoVision, Inc. Common Stock | 22.10x | — | 52.92% | -188.25% | $6.01 |
About
Masimo Corp develops, manufactures, and markets noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices, and consumer health products. The company serves hospitals, emergency medical services, home care providers, physician offices, veterinarians, and other healthcare customers.